EYES - Second Sight is up 17%; a patent grant cited as the reason

After a 38% rise in the premarket Second Sight Medical Products (EYES) is up ~17.9% today in an apparent reaction to a patent win by the company.Entitled "Uses for eye tracking in a visual prosthesis," the patent has been issued today according to the database of USPTO (the United States Patent and Trademark Office).The company has yet to make an official statement on the development.Second Sight Medical Products has dropped ~51.7% over the past 12-month period.With revenue declined by ~48.7% YoY in the trailing twelve-month period amid COVID-19 impact, the company decided to layoff staff and winddown certain operations in March, sending the shares 49% lower.

For further details see:

Second Sight is up 17%; a patent grant cited as the reason